Expert insights. Personalized for you.
digital therapeutics Related Topics 
TechCrunch
SEPTEMBER 9, 2021
Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digital therapeutics for neurodegenerative diseases.
OurCrowd
JULY 29, 2021
The post [Medisafe in Mobi Health News] Improving digital therapeutics in non-visit based care appeared first on OurCrowd Blog.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Tech Capital
DECEMBER 9, 2019
Digital therapeutics. back to fundamentals. will the patients use it? how do you get to the doctors to get a prescription (channel access with pharma reps is not working). and somebody willing to pay for it (payers
TechCrunch
DECEMBER 2, 2020
Neuroglee , a Singapore-based health tech startup, wants to help with a digital therapeutic platform created to treat patients in the early stages of the disease. SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis.
OurCrowd
JANUARY 13, 2021
The post [DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care D appeared first on OurCrowd Blog. Marilyn Ritholz, psychologist at Joslin Diabetes Center, a Harvard Medical School affiliate, and Dr. David Horwitz, former Global Chief Medical Officer of Johnson and Johnson Diabetes Institute, will help guide strategic and development roadmap.
OurCrowd
JUNE 18, 2020
Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m.
OurCrowd
SEPTEMBER 23, 2019
NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading, global digital therapeutics company, today announced that Erez Raphael, DarioHealth’s Chief Executive Officer, will be a speaker at the second annual DTx East 2019 conference taking place at Harvard Medical School in Boston, MA from September 24-26, 2019. DarioHealth Corp.
Leapfunder
JUNE 30, 2022
Ceriter's Stride One is a medically certified, digital therapeutic that helps patients with Parkinson's walk better and improves recovery for people who suffered a stroke
OurCrowd
NOVEMBER 4, 2021
Sweetch, a digital therapeutics innovator and creator of the hyper-personalized engagement platform for chronic conditions, recently announced the completion of a $20 million Series A round of funding.
Hyde Park Angels
MARCH 15, 2022
We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M in funding.
Hyde Park Angels
MARCH 15, 2022
We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M in funding.
|
OurCrowd
JANUARY 11, 2022
Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, today announced it has been named a winner in the 2022 BIG Innovation Awards healthcare category, presented by the Business Intelligence Group.
OurCrowd
DECEMBER 10, 2021
CB Insights on Thursday named Sweetch, a digital therapeutics innovator and creator of a hyper-personalized engagement platform for chronic conditions, to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world.
OurCrowd
APRIL 26, 2022
TEL AVIV, Israel, April 26, 2022 /PRNewswire/ — Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, announced today that Robert A.
TechCrunch
APRIL 6, 2022
As a venture firm that invests in psychedelics, we receive hundreds of pitches every month from founders developing psychedelic therapeutics. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. Matias Serebrinsky. Contributor. Share on Twitter.
TechCrunch
DECEMBER 20, 2021
4 strategies for building a digital health unicorn. The digital healthcare revolution has already begun, and it will gain further momentum in 2022 as providers and patients look for new and better ways to improve care. Digital therapeutics will rewrite the future of healthcare.
OurCrowd
DECEMBER 3, 2019
Global digital therapeutics innovation leader, DarioHealth Corp. NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. Read more here.
OurCrowd
JANUARY 21, 2021
Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the appointment of Chris Chan as Senior Vice President of Employer Sales. NEW YORK, Jan. 21, 2021 /PRNewswire/ — DarioHealth Corp.
OurCrowd
MAY 13, 2020
BOSTON, May 13, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, today announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services. Read more here.
OurCrowd
AUGUST 11, 2019
NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators (“AADE”) conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching.
OurCrowd
AUGUST 13, 2020
Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, Read more here.
OurCrowd
JUNE 14, 2020
Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services.
OurCrowd
MAY 6, 2020
Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S.
OurCrowd
MAY 4, 2020
NEW YORK, May 4, 2020 /PRNewswire/ — DarioHealth Corp.
OurCrowd
MARCH 28, 2022
Digital health is a new and challenging space for life sciences. The DTx Alliance’s best practices for digital therapeutics advise would-be developers to design products to optimize adoption, engagement and adherence within their target populations.
OurCrowd
MARCH 1, 2021
Today’s entrepreneur is Omri Shor is co-founder and CEO of Medisafe, a digital therapeutic companion company helping patients manage their treatment journey and medication therapies, which just raised a $30 million round of funding.
OurCrowd
FEBRUARY 16, 2022
. Today, Medisafe, a leading digital therapeutics and patient engagement company launches its new Digital Document Exchange module to streamline the medication approval process.
TechCrunch
NOVEMBER 3, 2021
As the world’s population ages, more is being learned about brain health as startups leverage technology to find a way to slow down cognitive impairment.
TechCrunch
OCTOBER 18, 2021
In October, Limbix, a company creating digital therapeutics for adolescents, released data from a trial on its new product: SparkRx. As one review paper in NPJ Digital Medicine notes, the median 15-day retention rate for mental health apps tends to be about 3.9%. .
OurCrowd
MAY 6, 2020
Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. DarioHealth Corp.
OurCrowd
FEBRUARY 24, 2020
NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace. The post [DarioHealth in Yahoo Finance] DarioHealth Digital Diabetes Management System is Now Available at Albertsons appeared first on OurCrowd. DarioHealth Corp.
TechCrunch
JULY 28, 2021
MedRhythms secured $25 million in Series B funding to advance its digital therapy platform aimed at measuring and improving someone’s ability to walk after they have experienced a neurologic injury or disease.
TechCrunch
FEBRUARY 10, 2022
With the recent funding, Atommerce plans to enhance artificial intelligence and machine learning technology for its platform and invest in digital therapeutics specialized in mental illness.
OurCrowd
JUNE 3, 2022
Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today three new research studies presented at the American Diabetes Association’s (“ADA”) 82 nd Scientific Sessions being held June 3 rd to 7 th , 2022 in New Orleans, Louisiana.
TechCrunch
MARCH 14, 2022
startup that offers personalized digital therapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus Ventures, along with participation from U.S.-based Vira Health , a U.K.
OurCrowd
OCTOBER 7, 2020
Digital therapeutics companion platform Medisafe has deployed its new Maestro platform, which aims to orchestrate medication adherence journeys with precision and speed and create personalized patient support resources.
85 
Let's personalize your content